Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Michael Asberry

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Computational and Structural Biotechnology Journal|November 16, 2022
Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiationAndrew Michael Asberry, Sheng Liu, Hye Seung Nam, et al.
The Prostate|July 18, 2025
PRMT5:MEP50 Are Mediators of Treatment-Induced Neuroendocrine Differentiation in Prostate CancerHye Seung Nam, Andrew Michael Asberry, Xuehong Deng, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Computational and Structural Biotechnology Journal|November 16, 2022
Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiationAndrew Michael Asberry, Sheng Liu, Hye Seung Nam, et al.
The Prostate|July 18, 2025
PRMT5:MEP50 Are Mediators of Treatment-Induced Neuroendocrine Differentiation in Prostate CancerHye Seung Nam, Andrew Michael Asberry, Xuehong Deng, et al.
Pageof 1